Peripheral serum copper metabolite levels measured by ultrafiltration aid in the clinical screening of Alzheimer’s disease

Frontiers in Psychiatry | New and Recent Articles ·
Mind & Mental Health Switzerland

BackgroundThe number of patients with Alzheimer’s disease (AD) is increasing, yet misdiagnosis remains common and early accurate diagnosis is lacking. Previous studies have suggested abnormalities in peripheral serum copper levels in AD patients. This study sought to explore the diagnostic value of peripheral serum copper-related biomarkers for clinically diagnosed AD.MethodsPeripheral serum…

Read original article on Frontiers in Psychiatry | New and Recent Articles →